Suit Against Merk & Co for Shingles Vaccine
Customers Launch Suit Against Merck for Allegedly Hazardous Shingles Vaccine
July 19, 2017
A suit filed in New Jersey state court alleges that pharmaceutical corporation Merck & Co., Inc., was negligent in failing to warn consumers of the potential health risks related to the company’s Zostavax shingles vaccine.
The 18 plaintiffs, who hail from 12 states, allege that Zostavax did not prevent shingles but in fact caused a particularly persistent strain of the disease, and that, for some plaintiffs, the disease turned into postherpetic neuralgia, a chronic, painful nerve condition.
Central to the suit is the claim that Merck not only made a potentially hazardous vaccine but that the company failed to adequately warn doctors and patients of the health risks of the drug.
A similar case is pending in a federal court in Pennsylvania.
More than 1100 complaints about Zostavax have been filed with the federal Vaccine Adverse Event Reporting System. Thirty-six of those cases have resulted in deaths.
Plaintiffs argue that a safer drug, Shingrix, was available for treatment of shingles, and that Merck should have known about that comparatively safer product.
If you’ve been injured by bad or improperly prescribed pharmaceuticals, you should see your doctor right away. Then, contact the expert attorneys at TheLawFirm.com to learn how we can help you with your case.
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!